Marinus Pharmaceuticals reported $112.49M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Adamas Pharmaceuticals ADMS:US 88.8M 36.03M
ALKERMES ALKS:US $ 258.34M 53.31M
Amgen AMGN:US $ 6630M 518M
Aptinyx Inc APTX:US $ 129.23M 17.58M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
Biogen BIIB:US $ 1742M 524.5M
Eisai 4523:JP Y 213082M 6097M
Enanta Pharmaceuticals ENTA:US $ 4.6M 72.53M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
Gilead Sciences GILD:US $ 7361M 3296M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
Intra Cellular Therapies ITCI:US $ 121.03M 8.95M
Marinus Pharmaceuticals MRNS:US $ 112.49M 10.98M
Minerva Neurosciences NERV:US $ 74.22M 5.92M
Neurocrine Biosciences NBIX:US $ 368M 15.4M
Ptc Therapeutics PTCT:US $ 177.35M 30.72M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Sarepta Therapeutics SRPT:US $ 1697.28M 215.44M
Supernus Pharmaceuticals SUPN:US $ 223.77M 31.87M
Vertex Pharmaceuticals VRTX:US $ 6063.68M 240.65M
YTE INCY:US $ 1797.58M 127.61M
Zogenix ZGNX:US $ 77.33M 38.36M